← All ABPN Flashcard Decks

ABPN Neuropharmacology and Psychopharmacology Flashcards

6 cards from real ABPN practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.

Read the first 6 ABPN Neuropharmacology and Psychopharmacology flashcards as text
  1. Which mechanism best describes how benzodiazepines produce their sedative-anxiolytic effects?

    Answer: Potentiate GABA-A chloride channel opening

    Benzodiazepines bind to GABA-A receptors and increase the frequency of chloride channel opening in response to GABA, enhancing inhibitory neurotransmission.

  2. Which antidepressant is CONTRAINDICATED in patients with a seizure disorder or eating disorders due to lowered seizure threshold?

    Answer: Bupropion

    Bupropion dose-dependently lowers the seizure threshold and is contraindicated in patients with seizure disorders or active eating disorders.

  3. A patient stabilized on olanzapine gains 25 pounds over 6 months and develops hyperglycemia. This best exemplifies which pharmacological mechanism?

    Answer: H1 histamine receptor antagonism and 5-HT2C blockade

    Olanzapine's metabolic side effects are primarily attributed to H1 and 5-HT2C receptor blockade, which increase appetite and impair glucose regulation.

  4. Which drug interaction is MOST clinically significant in a patient taking valproate who starts carbamazepine?

    Answer: Carbamazepine induces CYP enzymes, decreasing valproate levels

    Carbamazepine is a potent CYP3A4 inducer that significantly reduces valproate serum levels, potentially causing loss of seizure control.

  5. What is the mechanism by which acetylcholinesterase inhibitors improve symptoms in Alzheimer's disease?

    Answer: They increase acetylcholine availability at synapses

    Acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine) prevent the breakdown of acetylcholine, compensating for the cholinergic deficit in Alzheimer's disease.

  6. Which medication is FDA-approved for the treatment of alcohol use disorder by blocking opioid reward pathways?

    Answer: Naltrexone

    Naltrexone is an opioid receptor antagonist that reduces alcohol craving and pleasure by blocking the endogenous opioid reward pathway activated by alcohol.

How this page was made: written with AI tools and published by Nathan Beja, founder of Practice Test Geeks, who is responsible for its content. Exam facts are checked against the official sources listed below. Not reviewed by a subject-matter expert. Editorial policy

Sources & references

Exam facts on this page (fees, format, dates, passing scores) are checked against these official sources; the date is our last check. Editorial policy

  1. abpn.org — Fees, test delivery, renewal, exam dates, registration deadline, registration, passing score, exam format, time limit · verified Oct 2026